Skip to main content
Fig. 2 | BMC Pulmonary Medicine

Fig. 2

From: Comparison of frailty in patients with nontuberculous mycobacterial lung disease and bronchiectasis: a prospective cohort study

Fig. 2

Profiles of BALF (A) and serum (B) concentration of hCAP/LL-37 between patients with NTM and BE patients and the profiles of BALF (C, E) and serum (D, F) concentration of SP-A and SP-D between the two groups. hCAP/LL-37, human cationic antimicrobial protein and its C-terminal peptide; BALF, bronchoalveolar lavage fluid; NTM, nontuberculous mycobacteria; BE, bronchiectasis; SP-A, surfactant protein A; SP-D, surfactant protein D. n = 33 (NTM patients) and 36 (BE patients)

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us